InterLymph: At the Forefront of International Lymphoma Research

摘要 2019年，仅在美国，估计就有114,420人被确诊，33,930人将死于 非霍奇金淋巴瘤(NHL)、霍奇金淋巴瘤(HL)或多发性骨髓瘤(MM)。《国际邮报》 淋巴瘤流行病学(InterLymph)联盟聚集流行病学和相关领域的研究人员 对研究这些条件感兴趣的学科。InterLymph成立于2002年，拥有11名成员，现在 拥有81名调查人员，代表13个国家的57个机构。这是一项开放的科学论坛事业 合作研究项目，以更好地了解NHL、HL和MM的风险和预后因素。到目前为止， InterLymph成员成功完成了合作研究，出版了66 经过同行评审的手稿，并在几项备受瞩目的基因和基因研究发现中发挥了重要作用 环境风险因素。由8个工作组组成，这个由流行病学家组成的多样化社区， 统计学家、遗传学家、基础科学家和临床医生共同努力：(I)促进国际合作； (3)制定有效开展和发表合作研究的框架；。(2)为 讨论、发展和追求新的研究方向；以及(Iv)支持早期职业研究人员。 InterLymph年会定期有40-60名研究人员参加，这是一个值得分享的重要事件 正在进行的研究项目的进展，维护和扩展有价值的网络，计划下一步，并探索 新的协作想法。这是通过口头和海报演示以及圆桌讨论实现的。在……里面 此外，还邀请本地非成员专家分享他们的专业知识，以努力激发新的想法， 拓宽视野，加强我们的尖端科学。年度会议还提供了重要的 初级调查员和受训人员有机会培养专业关系并参与 思想交流。会议计划和主题由国际淋巴协调委员会制定 和会议主持人。2020年和2021年的会议将突出《InterLymph：在国际上处于领先地位》 淋巴瘤研究“。2020年，会议将在美国犹他州盐湖城举行。犹他州有很长一段时间 以家谱为基础的成功研究和创新的遗传和基因组技术的历史。因此， InterLymph 2020的主题是“系谱和基因组学”。将主办2021年国际淋巴会议 在法国里昂，国际癌症研究机构的所在地。随着巨无霸的到来 种群遗传数据库，如英国生物库，InterLymph 2021的主题将是 流行病学“。年度会议是保持合议性和持续进步的一种行之有效的手段 淋巴肿瘤的联合研究。这项会议提案将通过以下方式为我们的成功做出重大贡献 提供提供旅游奖励和网络活动的能力，这将增加 与会者和会议的整体价值。

ABSTRACT In 2019, an estimated 114,420 individuals in the United States alone will be diagnosed and 33,930 will die from non-Hodgkin lymphoma (NHL), Hodgkin lymphoma (HL) or multiple myeloma (MM). The International Lymphoma Epidemiology (InterLymph) consortium assembles researchers in epidemiology and related disciplines interested in studying these conditions. Established in 2002 with 11 members, InterLymph now boasts 81 investigators representing 57 institutions in 13 countries. It is an open scientific forum undertaking collaborative research projects to better understand risk and prognostic factors of NHL, HL and MM. Thus far, InterLymph members have successfully completed collaborative research resulting in the publication of 66 peer-reviewed manuscripts and played a significant role in several high-profile discoveries of genetic and environmental risk factors. Structured around 8 working groups, this diverse community of epidemiologists, statisticians, geneticists, basic scientists and clinicians work together to: (I) foster international collaborations; (III) develop a framework to efficiently conduct and publish collaborative studies; (II) provide a forum for the discussion, development and pursuit of new research directions; and (IV) support early career researchers. The InterLymph annual meeting, regularly attended by 40-60 investigators, is an important event to share progress of on-going research projects, maintain and expand valuable networks, plan next steps, and explore new collaborative ideas. This is achieved with oral and poster presentations and round-table discussions. In addition, local non-member experts are invited to share their expertise in an effort to stimulate new ideas, broaden perspective and strengthen our cutting-edge science. Annual meetings also provide important opportunities for junior investigators and trainees to foster professional relationships and participate in the exchange of ideas. Meeting programs and themes are developed by the InterLymph Coordinating Committee and the meeting host. The 2020 and 2021 meetings will highlight “InterLymph: At the Forefront of International Lymphoma Research”. In 2020, the meeting will be hosted in Salt Lake City, Utah, USA. Utah has a long history of successful genealogy-based studies and innovative genetic and genomic techniques. Accordingly, the InterLymph 2020 theme will be “Genealogy and Genomics”. The 2021 InterLymph meeting will be hosted in Lyon, France, the home of the International Agency for Research on Cancer. With the advent of huge population genetic databases, such as the UK biobank, the InterLymph 2021 theme will be “Big Data in Epidemiology”. Annual meetings are a proven means to maintaining collegiality and sustaining advances in joint research of lymphoid neoplasms. This conference proposal will contribute significantly to our success by providing the ability to offer travel awards and networking events, which will increase the diversity of attendees and overall value of the meetings.